U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry EPIMERIC
Molecular Formula C38H74O10P.Na
Molecular Weight 744.9517
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL)

SMILES

[Na+].CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC

InChI

InChIKey=LDWIWSHBGAIIMV-ODZMYOIVSA-M
InChI=1S/C38H75O10P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-37(41)45-33-36(34-47-49(43,44)46-32-35(40)31-39)48-38(42)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h35-36,39-40H,3-34H2,1-2H3,(H,43,44);/q;+1/p-1/t35?,36-;/m1./s1

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C38H74O10P
Molecular Weight 721.9619
Charge -1
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry EPIMERIC
Additional Stereochemistry No
Defined Stereocenters 1 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

1,2-Dipalmitoyl-sn-glycero-3-phosphorylglycerol sodium salt (DPPG) is phosphorylglycerol acylated with palmitic acid, that can be used for the preparation of liposomes with negatively charged hydrophilic head groups.

Originator

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Inactive ingredient
Unknown
Inactive ingredient
Unknown
Diagnostic
LUMASON
Diagnostic
LUMASON
Diagnostic
LUMASON

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Samples containing 2.6 mmol of phospholipids (DMPCd54 plus either DMPA or DMPG at a 3:1 molar ratio) dissolved in chloroform/methanol (1:1 v/v) were mixed alone or with a-MSH, also in the same solvent, to give a final phospholipid to peptide molar ratio of 10:1. The mixtures were dried under vacuum for 3 h to remove all traces of the organic solvents. Then, multilamellar vesicles (MLV) were formed in 1.4 ml buffer heated at a temperature ;10°C above the temperature of the gel-to-liquid-crystalline phase transition (Tm) of the mixture and frozen at 280°C, this process being repeated five times. Differential scanning calorimetry was performed in a high-resolution Microcal MC-2 calorimeter (Microcal Inc., Northampton, MA). Differences in the heat capacity between the sample and the reference cell were obtained by raising the temperature at a constant rate of 45°C/h over a temperature range of 5–60°C. The excess heat capacity functions were obtained after baseline subtraction and correction for the instrument time response. Unless otherwise stated, the third scan was used for transition temperature and enthalpy calculation
Substance Class Chemical
Record UNII
841B886EJ7
Record Status Validated (UNII)
Record Version